Compare Align Technology, Inc. (ALGN) vs Freeport-McMoRan Inc (FCX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Align Technology, Inc. vs Freeport-McMoRan Inc — how do they compare? Align Technology, Inc. trades at $175.74 (market cap $12.36B), while Freeport-McMoRan Inc trades at $66.9 (market cap $96.91B). The key difference: Freeport-McMoRan Inc is far larger — about 7.8× Align Technology, Inc.'s market cap, and Freeport-McMoRan Inc pays a 0.87% dividend while Align Technology, Inc. pays none. Which is the better fit depends on your goals.
| ALGN | FCX | |
|---|---|---|
Market Cap | $12.36B | $96.91B |
Sector | Health | Basic Materials |
52-Week High | $197.51 | $71.73 |
52-Week Low | $124.88 | $35.34 |
Enterprise Value | $11.38B | $103.19B |
Dividend Yield | — | 0.87% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ALGN trades at $176.20, up 1.88% today, with a bearish technical signal but strong fundamentals including a 68.05% gross margin and three consecutive quarterly earnings beats. Recent news highlights a patent win in China and strategic board changes following activist engagement, while cash flow trends show improving net cash generation from $51M in 2025 to a projected $202M in 2026.
The stock offers value with a P/E of 30.21 near five-year lows, supported by 72.73% analyst buy ratings, but faces risks from scanner segment pressure and North American growth stagnation. Upside hinges on international expansion and digital platform execution amid competitive and macroeconomic headwinds.
FCX trades at $66.83, down 2.98% on the day, but maintains a bullish technical trend with strong analyst support. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 expected at $0.72 EPS. Revenue remains stable around $25.9B, while net income margin improved to 11.38% in 2026. Recent news highlights operational challenges like lower copper volumes but also growth initiatives at Grasberg and Bagdad.
The outlook is positive with a consensus price target of $73.85, implying ~10% upside. Key opportunities include exposure to high copper prices and expansion projects, while risks involve production volatility, cost pressures, and reliance on commodity cycles. The stock's valuation appears elevated with a P/E of 33.93, requiring sustained earnings growth to justify further gains.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Align Technology, Inc.
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →About Freeport-McMoRan Inc
Freeport-McMoRan Inc is an international mining company. It operates geographically diverse assets with proven and probable mineral reserves of copper, gold and molybdenum. The company's portfolio of assets includes the Grasberg minerals district in Indonesia
Read more on FCX →
